Novartis Ophthalmics a global leader in research, development and manufacturing of innovative ophthalmic pharmaceuticals that assist in the treatment of Age-related Macular Degeneration, infections, inflammation, ocular allergies, dry eye and other diseases and disorders of the eye.
 

You may have known us as CIBA Vision Ophthalmics, a business that has achieved phenomenal success in the area of eye health during the past 10 years.
 

Now as Novartis Ophthalmics, our vision is to deliver the next generation of breakthrough ophthalmic products to doctors and their patients.
 

As part of our parent company, Novartis, Novartis Ophthalmics shares immense global resources and scientific expertise, especially in the area of research and development.